These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7908055)

  • 1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
    Roth BL; Craigo SC; Choudhary MS; Uluer A; Monsma FJ; Shen Y; Meltzer HY; Sibley DR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1403-10. PubMed ID: 7908055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.
    Roth BL; Ciaranello RD; Meltzer HY
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1361-5. PubMed ID: 1347569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L; Savage JE; Meltzer HY; Roth BL
    J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
    Herrick-Davis K; Grinde E; Teitler M
    J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.
    Roth BL; Tandra S; Burgess LH; Sibley DR; Meltzer HY
    Psychopharmacology (Berl); 1995 Aug; 120(3):365-8. PubMed ID: 8524985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
    Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
    Malmberg A; Jackson DM; Eriksson A; Mohell N
    Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
    Meltzer HY; Matsubara S; Lee JC
    Psychopharmacol Bull; 1989; 25(3):390-2. PubMed ID: 2576319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat.
    Cahir M; King DJ
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):231-4. PubMed ID: 15695070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
    Villalón CM; Heiligers JP; Centurión D; De Vries P; Saxena PR
    Br J Pharmacol; 1997 Jul; 121(6):1187-95. PubMed ID: 9249256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
    Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
    Kapur S; Seeman P
    J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
    Meltzer HY; Matsubara S; Lee JC
    J Pharmacol Exp Ther; 1989 Oct; 251(1):238-46. PubMed ID: 2571717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.